The many faces of p38 mitogen-activated protein kinase in progenitor/stem cell differentiation

Biochemical Journal

Volumn 445, Issue 1, 2012, Pages 1-10

  Oeztuerk Winder, Feride ^a   Ventura, Juan Jose ^a  

^a University of Cambridge   (United Kingdom)

Author keywords

Cancer; Cell specification; Cytokine signalling; Development; Mitogen activated protein kinase (MAPK); Self renewal

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; NOTCH RECEPTOR; WNT PROTEIN;

CELL DIFFERENTIATION; CELL FUNCTION; CELL RENEWAL; CELL TYPE; DOWNSTREAM PROCESSING; EPITHELIUM CELL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; MUSCLE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

ADULT; ANIMALS; CELL DIFFERENTIATION; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; STEM CELLS;

EID: 84862500325     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20120401     Document Type: Review

References (169)

1. Czyz, J. and Wobus, A. (2001) Embryonic stem cell differentiation: the role of extracellular factors. Differentiation 68, 167-174 (Pubitemid 33754989)
2. Iglesias-Bartolome, R. and Gutkind, J. S. (2011) Signaling circuitries controlling stem cell fate: to be or not to be. Curr. Opin. Cell Biol. 23, 716-723
3. Watt, F. M. (2002) Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J. 21, 3919-3926
4. Raman, M., Chen, W. and Cobb, M. H. (2007) Differential regulation and properties of MAPKs. Oncogene 26, 3100-3112 (Pubitemid 46763006)
5. Nebreda, A. R. and Porras, A. (2000) p38 MAP kinases: beyond the stress response. Trends Biochem. Sci. 25, 257-260 (Pubitemid 30333380)
6. Cohen, P. (2009) Targeting protein kinases for the development of anti-inflammatory drugs. Curr. Opin. Cell Biol. 21, 317-324
7. Jiang, Y., Li, Z., Schwarz, E. M., Lin, A., Guan, K., Ulevitch, R. J. and Han, J. (1997) Structure-function studies of p38 mitogen-activated protein kinase. Loop 12 influences substrate specificity and autophosphorylation, but not upstream kinase selection. J. Biol. Chem. 272, 11096-11102 (Pubitemid 27184100)
8. Ono, K. and Han, J. (2000) The p38 signal transduction pathway: activation and function. Cell. Signalling 12, 1-13 (Pubitemid 30017963)
9. Kyriakis, J. M. and Avruch, J. (1996) Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 18, 567-577 (Pubitemid 26311096)
10. Kyriakis, J. M. and Avruch, J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807-869 (Pubitemid 32267078)
11. Guo, J. H., Wang, H. Y. and Malbon, C. C. (1998) Conditional, tissue-specific expression of Q205L Gαi2 in vivo mimics insulin activation of c-Jun N-terminal kinase and p38 kinase. J. Biol. Chem. 273, 16487-16493
12. Adams, R. H., Porras, A., Alonso, G., Jones, M., Vintersten, K., Panelli, S., Valladares, A., Perez, L., Klein, R. and Nebreda, A. R. (2000) Essential role of p38α MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell 6, 109-116
13. Cobb, M. H. and Goldsmith, E. J. (1995) How MAP kinases are regulated. J. Biol. Chem. 270, 14843-14846
14. Cuadrado, A. and Nebreda, A. R. (2010) Mechanisms and functions of p38 MAPK signalling. Biochem. J. 429, 403-417
15. Rose, B. A., Force, T. and Wang, Y. (2010) Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol. Rev. 90, 1507-1546
16. Roux, P. P. and Blenis, J. (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68, 320-344 (Pubitemid 38756868)
17. Suzanne, M., Irie, K., Glise, B., Agnes, F., Mori, E., Matsumoto, K. and Noselli, S. (1999) The Drosophila p38 MAPK pathway is required during oogenesis for egg asymmetric development. Genes Dev. 13, 1464-1474 (Pubitemid 29270250)
18. Fujii, R., Yamashita, S., Hibi, M. and Hirano, T. (2000) Asymmetric p38 activation in zebrafish: its possible role in symmetric and synchronous cleavage. J. Cell. Biol. 150, 1335-1348
19. Holloway, B. A., Gomez de la Torre Canny, S., Ye, Y., Slusarski, D. C., Freisinger, C. M., Dosch, R., Chou, M. M., Wagner, D. S. and Mullins, M. C. (2009) A novel role for MAPKAPK2 in morphogenesis during zebrafish development. PLoS Genet. 5, e1000413
20. Keren, A., Bengal, E. and Frank, D. (2005) p38 MAP kinase regulates the expression of XMyf5 and affects distinct myogenic programs during Xenopus development. Dev. Biol. 288, 73-86 (Pubitemid 41713155)
21. Allen, M., Svensson, L., Roach, M., Hambor, J., McNeish, J. and Gabel, C. A. (2000) Deficiency of the stress kinase p38α results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J. Exp. Med. 191, 859-870
22. Mudgett, J. S., Ding, J., Guh-Siesel, L., Chartrain, N. A., Yang, L., Gopal, S. and Shen, M. M. (2000) Essential role for p38α mitogen-activated protein kinase in placental angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 97, 10454-10459
23. Brancho, D., Tanaka, N., Jaeschke, A., Ventura, J. J., Kelkar, N., Tanaka, Y., Kyuuma, M., Takeshita, T., Flavell, R. A. and Davis, R. J. (2003) Mechanism of p38 MAP kinase activation in vivo. Genes Dev. 17, 1969-1978 (Pubitemid 36999324)
24. Natale, D. R., Paliga, A. J., Beier, F., D'Souza, S. J. and Watson, A. J. (2004) p38 MAPK signaling during murine preimplantation development. Dev. Biol. 268, 76-88 (Pubitemid 38367851)
25. Han, J., Richter, B., Li, Z., Kravchenko, V. and Ulevitch, R. J. (1995) Molecular cloning of human p38 MAP kinase. Biochim. Biophys. Acta 1265, 224-227
26. Kim, S. J., Ko, C. B., Park, C., Kim, B. R., Sung, T. H., Koh, D. H., Kim, N. S., Oh, K. J., Chung, S. Y. and Park, R. (2005) p38 MAP kinase regulates benzo(a)pyrene-induced apoptosis through the regulation of p53 activation. Arch. Biochem. Biophys. 444, 121-129 (Pubitemid 41728344)
27. Guo, Y. L. and Yang, B. (2006) Altered cell adhesion and cell viability in a p38α mitogen-activated protein kinase-deficient mouse embryonic stem cell line. Stem Cells Dev. 15, 655-664
28. Guo, Y. L., Ye, J. and Huang, F. (2007) p38α MAP kinase-deficient mouse embryonic stem cells can differentiate to endothelial cells, smooth muscle cells and neurons. Dev. Dyn. 236, 3383-3392 (Pubitemid 350276394)
29. Barruet, E., Hadadeh, O., Peiretti, F., Renault, V. M., Hadjal, Y., Bernot, D., Tournaire, R., Negre, D., Juhan-Vague, I., Alessi, M. C. et al. (2011) p38 mitogen activated protein kinase controls two successive-steps during the early mesodermal commitment of embryonic stem cells. Stem Cells Dev. 20, 1233-1246
30. Beardmore, V. A., Hinton, H. J., Eftychi, C., Apostolaki, M., Armaka, M., Darragh, J., McIlrath, J., Carr, J. M., Armit, L. J., Clacher, C. et al. (2005) Generation and characterization of p38β MAPK11) gene-targeted mice. Mol. Cell Biol. 25, 10454-10464 (Pubitemid 41681967)
31. Sabio, G., Arthur, J. S., Kuma, Y., Peggie, M., Carr, J., Murray-Tait, V., Centeno, F., Goedert, M., Morrice, N. A. and Cuenda, A. (2005) p38γ regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J. 24, 1134-1145 (Pubitemid 40516597)
32. Hui, L., Bakiri, L., Mairhorfer, A., Schweifer, N., Haslinger, C., Kenner, L., Komnenovic, V., Scheuch, H., Beug, H. and Wagner, E. F. (2007) p38α suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat. Genet. 39, 741-749 (Pubitemid 46848584)
33. Aouadi, M., Bost, F., Caron, L., Laurent, K., Le Marchand Brustel, Y. and Binetruy, B. (2006) p38 mitogen-activated protein kinase activity commits embryonic stem cells to either neurogenesis or cardiomyogenesis. Stem Cells 24, 1399-1406 (Pubitemid 44464708)
34. Aouadi, M., Laurent, K., Prot, M., Le Marchand-Brustel, Y., Binetruy, B. and Bost, F. (2006) Inhibition of p38MAPK increases adipogenesis from embryonic to adult stages. Diabetes 55, 281-289 (Pubitemid 43343254)
35. Awad, M. M., Enslen, H., Boylan, J. M., Davis, R. J. and Gruppuso, P. A. (2000) Growth regulation via p38 mitogen-activated protein kinase in developing liver. J. Biol. Chem. 275, 38716-38721 (Pubitemid 32009206)
36. Liu, Y., Martinez, L., Ebine, K. and Abe, M. K. (2008) Role for mitogen-activated protein kinase p38α in lung epithelial branching morphogenesis. Dev. Biol. 314, 224-235
37. Ventura, J. J., Tenbaum, S., Perdiguero, E., Huth, M., Guerra, C., Barbacid, M., Pasparakis, M. and Nebreda, A. R. (2007) p38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat. Genet. 39, 750-758 (Pubitemid 46848588)
38. Perdiguero, E., Ruiz-Bonilla, V., Gresh, L., Hui, L., Ballestar, E., Sousa-Victor, P., Baeza-Raja, B., Jardi, M., Bosch-Comas, A., Esteller, M. et al. (2007) Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38α in abrogating myoblast proliferation. EMBO J. 26, 1245-1256 (Pubitemid 46398710)
39. Engel, F. B., Schebesta, M., Duong, M. T., Lu, G., Ren, S., Madwed, J. B., Jiang, H., Wang, Y. and Keating, M. T. (2005) p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev. 19, 1175-1187 (Pubitemid 40696184)
40. Kang, Y. J., Chen, J., Otsuka, M., Mols, J., Ren, S., Wang, Y. and Han, J. (2008) Macrophage deletion of p38α partially impairs lipopolysaccharide-induced cellular activation. J. Immunol. 180, 5075-5082
41. Kim, C., Sano, Y., Todorova, K., Carlson, B. A., Arpa, L., Celada, A., Lawrence, T., Otsu, K., Brissette, J. L., Arthur, J. S. et al. (2008) The kinase p38α serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nat. Immunol. 9, 1019-1027
42. Wong, E. S., Le Guezennec, X., Demidov, O. N., Marshall, N. T., Wang, S. T., Krishnamurthy, J., Sharpless, N. E., Dunn, N. R. and Bulavin, D. V. (2009) p38MAPK controls expression of multiple cell cycle inhibitors and islet proliferation with advancing age. Dev. Cell 17, 142-149
43. Nagata, Y., Moriguchi, T., Nishida, E. and Todokoro, K. (1997) Activation of p38 MAP kinase pathway by erythropoietin and interleukin-3. Blood 90, 929-934 (Pubitemid 27314124)
44. Verma, A., Deb, D. K., Sassano, A., Uddin, S., Varga, J., Wickrema, A. and Platanias, L. C. (2002) Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-β on normal hematopoiesis. J. Biol. Chem. 277, 7726-7735 (Pubitemid 34968219)
45. Katsoulidis, E., Li, Y., Mears, H. and Platanias, L. C. (2005) The p38 mitogen-activated protein kinase pathway in interferon signal transduction. J. Interferon Cytokine Res. 25, 749-756 (Pubitemid 43068486)
46. Jacobs-Helber, S. M., Ryan, J. J. and Sawyer, S. T. (2000) JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells. Blood 96, 933-940 (Pubitemid 30616857)
47. Rincon, M. and Pedraza-Alva, G. (2003) JNK and p38 MAP kinases in CD4+ and CD8+ T cells. Immunol. Rev. 192, 131-142 (Pubitemid 36613329)
48. Diehl, N. L., Enslen, H., Fortner, K. A., Merritt, C., Stetson, N., Charland, C., Flavell, R. A., Davis, R. J. and Rincon, M. (2000) Activation of the p38 mitogen-activated protein kinase pathway arrests cell cycle progression and differentiation of immature thymocytes in vivo. J. Exp. Med. 191, 321-334 (Pubitemid 30060921)
49. Rincon, M., Enslen, H., Raingeaud, J., Recht, M., Zapton, T., Su, M. S., Penix, L. A., Davis, R. J. and Flavell, R. A. (1998) Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17, 2817-2829
50. Merritt, C., Enslen, H., Diehl, N., Conze, D., Davis, R. J. and Rincon, M. (2000) Activation of p38 mitogen-activated protein kinase in vivo selectively induces apoptosis of CD8+ but not CD4+ T cells. Mol. Cell Biol. 20, 936-946 (Pubitemid 30044231)
51. Alvarado-Kristensson, M., Melander, F., Leandersson, K., Ronnstrand, L., Wernstedt, C. and Andersson, T. (2004) p38-MAPK signals survival by phosphorylation of caspase-8 and caspase-3 in human neutrophils. J. Exp. Med. 199, 449-458 (Pubitemid 38233829)
52. Alvarado-Kristensson, M., Porn-Ares, M. I., Grethe, S., Smith, D., Zheng, L. and Andersson, T. (2002) p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase activities have opposite effects on human neutrophil apoptosis. FASEB J. 16, 129-131
53. Kankaanranta, H., De Souza, P. M., Barnes, P. J., Salmon, M., Giembycz, M. A. and Lindsay, M. A. (1999) SB 203580, an inhibitor of p38 mitogen-activated protein kinase, enhances constitutive apoptosis of cytokine-deprived human eosinophils. J. Pharmacol Exp. Ther. 290, 621-628 (Pubitemid 29344554)
54. Navas, T. A., Mohindru, M., Estes, M., Ma, J. Y., Sokol, L., Pahanish, P., Parmar, S., Haghnazari, E., Zhou, L., Collins, R. et al. (2006) Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors. Blood 108, 4170-4177 (Pubitemid 44913289)
55. Otsuka, M., Kang, Y. J., Ren, J., Jiang, H., Wang, Y., Omata, M. and Han, J. (2010) Distinct effects of p38α deletion in myeloid lineage and gut epithelia in mouse models of inflammatory bowel disease. Gastroenterology 138, 1255-1265
56. Buck, I., Morceau, F., Cristofanon, S., Heintz, C., Chateauvieux, S., Reuter, S., Dicato, M. and Diederich, M. (2008) Tumor necrosis factor α inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation. Biochem. Pharmacol. 76, 1229-1239
57. Geest, C. R., Buitenhuis, M., Laarhoven, A. G., Bierings, M. B., Bruin, M. C., Vellenga, E. and Coffer, P. J. (2009) p38 MAP kinase inhibits neutrophil development through phosphorylation of C/EBPα on serine 21. Stem Cells 27, 2271-2282
58. Kale, V. P. (2004) Differential activation of MAPK signaling pathways by TGF-β1 forms the molecular mechanism behind its dose-dependent bidirectional effects on hematopoiesis. Stem Cells Dev. 13, 27-38
59. Vijayaraj, P., Kroeger, C., Reuter, U., Hartmann, D. and Magin, T. M. (2010) Keratins regulate yolk sac hematopoiesis and vasculogenesis through reduced BMP-4 signaling. Eur. J. Cell Biol. 89, 299-306
60. Keren, A., Tamir, Y. and Bengal, E. (2006) The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol. Cell. Endocrinol. 252, 224-230
61. Lluis, F., Perdiguero, E., Nebreda, A. R. and Munoz-Canoves, P. (2006) Regulation of skeletal muscle gene expression by p38 MAP kinases. Trends Cell Biol. 16, 36-44 (Pubitemid 43077093)
62. Adams, R. D. and Walton, J. N. (1956) The response of the normal, the denervated and the dystrophic muscle-cell to injury. J. Pathol. Bacteriol. 72, 273-298
63. Legros, J. (1946) [Not Available]. Acta Paediatr. Belg. 1, 80-82
64. Mauro, A. (1961) Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 9, 493-495
65. Jones, N. C., Tyner, K. J., Nibarger, L., Stanley, H. M., Cornelison, D. D., Fedorov, Y. V. and Olwin, B. B. (2005) The p38α/β MAPK functions as a molecular switch to activate the quiescent satellite cell. J. Cell Biol. 169, 105-116 (Pubitemid 40562918)
66. Wu, Z., Woodring, P. J., Bhakta, K. S., Tamura, K., Wen, F., Feramisco, J. R., Karin, M., Wang, J. Y. and Puri, P. L. (2000) p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol. Cell Biol. 20, 3951-3964 (Pubitemid 30314494)
67. Lluis, F., Ballestar, E., Suelves, M., Esteller, M. and Munoz-Canoves, P. (2005) E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription. EMBO J. 24, 974-984 (Pubitemid 40470146)
68. Zetser, A., Gredinger, E. and Bengal, E. (1999) p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J. Biol. Chem. 274, 5193-5200
69. Suelves, M., Lluis, F., Ruiz, V., Nebreda, A. R. and Munoz-Canoves, P. (2004) Phosphorylation of MRF4 transactivation domain by p38 mediates repression of specific myogenic genes. EMBO J. 23, 365-375 (Pubitemid 38294501)
70. Weston, A. D., Sampaio, A. V., Ridgeway, A. G. and Underhill, T. M. (2003) Inhibition of p38 MAPK signaling promotes late stages of myogenesis. J. Cell Sci. 116, 2885-2893 (Pubitemid 36926978)
71. Ruiz-Bonilla, V., Perdiguero, E., Gresh, L., Serrano, A. L., Zamora, M., Sousa-Victor, P., Jardi, M., Wagner, E. F. and Munoz-Canoves, P. (2008) Efficient adult skeletal muscle regeneration in mice deficient in p38β, p38γ and p38δ MAP kinases. Cell Cycle 7, 2208-2214 (Pubitemid 352031523)
72. Perdiguero, E., Sousa-Victor, P., Ruiz-Bonilla, V., Jardi, M., Caelles, C., Serrano, A. L. and Munoz-Canoves, P. (2011) p38/MKP-1-regulated AKT coordinates macrophage transitions and resolution of inflammation during tissue repair. J. Cell Biol. 195, 307-322
73. Chen, C. Y., Gherzi, R., Andersen, J. S., Gaietta, G., Jurchott, K., Royer, H. D., Mann, M. and Karin, M. (2000) Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev. 14, 1236-1248 (Pubitemid 30327504)
74. Nemoto, S., Sheng, Z. and Lin, A. (1998) Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol. Cell Biol. 18, 3518-3526 (Pubitemid 28240524)
75. Porras, A., Zuluaga, S., Black, E., Valladares, A., Alvarez, A. M., Ambrosino, C., Benito, M. and Nebreda, A. R. (2004) p38α mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol. Biol. Cell 15, 922-933 (Pubitemid 38146504)
76. Zechner, D., Craig, R., Hanford, D. S., McDonough, P. M., Sabbadini, R. A. and Glembotski, C. C. (1998) MKK6 activates myocardial cell NF-κB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J. Biol. Chem. 273, 8232-8239 (Pubitemid 28168880)
77. Khurana, A. and Dey, C. S. (2004) Involvement of c-Jun N-terminal kinase activities in skeletal muscle differentiation. J. Muscle Res. Cell Motil. 25, 645-655 (Pubitemid 40562030)
78. Meriane, M., Roux, P., Primig, M., Fort, P. and Gauthier-Rouviere, C. (2000) Critical activities of Rac1 and Cdc42Hs in skeletal myogenesis: antagonistic effects of JNK and p38 pathways. Mol. Biol. Cell 11, 2513-2528 (Pubitemid 30645023)
79. Bakiri, L., Lallemand, D., Bossy-Wetzel, E. and Yaniv, M. (2000) Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO J. 19, 2056-2068 (Pubitemid 30237581)
80. Perdiguero, E., Ruiz-Bonilla, V., Serrano, A. L. and Munoz-Canoves, P. (2007) Genetic deficiency of p38α reveals its critical role in myoblast cell cycle exit: the p38α-JNK connection. Cell Cycle 6, 1298-1303 (Pubitemid 47327960)
81. Trouillas, M., Saucourt, C., Duval, D., Gauthereau, X., Thibault, C., Dembele, D., Feraud, O., Menager, J., Rallu, M., Pradier, L. et al. (2008) Bcl2, a transcriptional target of p38α, is critical for neuronal commitment of mouse embryonic stem cells. Cell Death Differ. 15, 1450-1459
82. Wu, J., Kubota, J., Hirayama, J., Nagai, Y., Nishina, S., Yokoi, T., Asaoka, Y., Seo, J., Shimizu, N., Kajiho, H. et al. (2010) p38 mitogen-activated protein kinase controls a switch between cardiomyocyte and neuronal commitment of murine embryonic stem cells by activating myocyte enhancer factor 2C-dependent bone morphogenetic protein 2 transcription. Stem Cells Dev. 19, 1723-1734
83. Chai, Z., Yang, L., Yu, B., He, Q., Li, W. I., Zhou, R., Zhang, T., Zheng, X. and Xie, J. (2009) p38 mitogen-activated protein kinase-dependent regulation of SRC-3 and involvement in retinoic acid receptor α signaling in embryonic cortical neurons. IUBMB Life 61, 670-678
84. Strassburger, M., Braun, H. and Reymann, K. G. (2008) Anti-inflammatory treatment with the p38 mitogen-activated protein kinase inhibitor SB239063 is neuroprotective, decreases the number of activated microglia and facilitates neurogenesis in oxygen-glucose-deprived hippocampal slice cultures. Eur. J. Pharmacol. 592, 55-61
85. Zhang, D., Guo, M., Zhang, W. and Lu, X. Y. (2011) Adiponectin stimulates proliferation of adult hippocampal neural stem/progenitor cells through activation of p38 mitogen-activated protein kinase (p38MAPK)/glycogen synthase kinase 3β (GSK-3β)/β-catenin signaling cascade. J. Biol. Chem. 286, 44913-44920
86. Oh, J. E., Bae, G. U., Yang, Y. J., Yi, M. J., Lee, H. J., Kim, B. G., Krauss, R. S. and Kang, J. S. (2009) Cdo promotes neuronal differentiation via activation of the p38 mitogen-activated protein kinase pathway. FASEB J. 23, 2088-2099
87. Chew, L. J., Coley, W., Cheng, Y. and Gallo, V. (2010) Mechanisms of regulation of oligodendrocyte development by p38 mitogen-activated protein kinase. J. Neurosci. 30, 11011-11027
88. Okamoto, S., Krainc, D., Sherman, K. and Lipton, S. A. (2000) Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. Proc. Natl. Acad. Sci. U.S.A. 97, 7561-7566 (Pubitemid 30431503)
89. Walshe, T. E., Leach, L. L. and D'Amore, P. A. (2011) TGF-β signaling is required for maintenance of retinal ganglion cell differentiation and survival. Neuroscience 189, 123-131
90. Murry, T., Tabaee, A., Owczarzak, V. and Aviv, J. E. (2006) Respiratory retraining therapy and management of laryngopharyngeal reflux in the treatment of patients with cough and paradoxical vocal fold movement disorder. Ann. Otol. Rhinol. Laryngol. 115, 754-758 (Pubitemid 44582870)
91. Poss, K. D., Wilson, L. G. and Keating, M. T. (2002) Heart regeneration in zebrafish. Science 298, 2188-2190 (Pubitemid 35471243)
92. Raya, A., Koth, C. M., Buscher, D., Kawakami, Y., Itoh, T., Raya, R. M., Sternik, G., Tsai, H. J., Rodriguez-Esteban, C. and Izpisua-Belmonte, J. C. (2003) Activation of Notch signaling pathway precedes heart regeneration in zebrafish. Proc. Natl. Acad. Sci. U.S.A. 100 (Suppl. 1), 11889-11895 (Pubitemid 37205900)
93. Nadal-Ginard, B. (1978) Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell 15, 855-864
94. Tam, S. K., Gu, W., Mahdavi, V. and Nadal-Ginard, B. (1995) Cardiac myocyte terminal differentiation. Potential for cardiac regeneration. Ann. NY Acad. Sci. 752, 72-79
95. Beltrami, A. P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara, H., Rota, M., Musso, E., Urbanek, K. et al. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114, 763-776 (Pubitemid 37186770)
96. Oh, H., Bradfute, S. B., Gallardo, T. D., Nakamura, T., Gaussin, V., Mishina, Y., Pocius, J., Michael, L. H., Behringer, R. R., Garry, D. J. et al. (2003) Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. U.S.A. 100, 12313-12318 (Pubitemid 37271557)
97. Martin, R. L., McDermott, J. S., Salmen, H. J., Palmatier, J., Cox, B. F. and Gintant, G. A. (2004) The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: influence of multi-channel block. J. Cardiovasc. Pharmacol. 43, 369-379 (Pubitemid 38270603)
98. Matsuura, K., Nagai, T., Nishigaki, N., Oyama, T., Nishi, J., Wada, H., Sano, M., Toko, H., Akazawa, H., Sato, T. et al. (2004) Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J. Biol. Chem. 279, 11384-11391 (Pubitemid 38401637)
99. Messina, E., De Angelis, L., Frati, G., Morrone, S., Chimenti, S., Fiordaliso, F., Salio, M., Battaglia, M., Latronico, M. V., Coletta, M. et al. (2004) Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95, 911-921 (Pubitemid 39435006)
100. Laugwitz, K. L., Moretti, A., Lam, J., Gruber, P., Chen, Y., Woodard, S., Lin, L. Z., Cai, C. L., Lu, M. M., Reth, M. et al. (2005) Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433, 647-653 (Pubitemid 40282999)
101. Leri, A., Kajstura, J. and Anversa, P. (2005) Cardiac stem cells and mechanisms of myocardial regeneration. Physiol. Rev. 85, 1373-1416 (Pubitemid 41362274)
102. Eriksson, M. and Leppa, S. (2002) Mitogen-activated protein kinases and activator protein 1 are required for proliferation and cardiomyocyte differentiation of P19 embryonal carcinoma cells. J. Biol. Chem. 277, 15992-16001 (Pubitemid 34967882)
103. Tenhunen, O., Sarman, B., Kerkela, R., Szokodi, I., Papp, L., Toth, M. and Ruskoaho, H. (2004) Mitogen-activated protein kinases p38 and ERK 1/2 mediate the wall stress-induced activation of GATA-4 binding in adult heart. J. Biol. Chem. 279, 24852-24860 (Pubitemid 38725353)
104. Han, J. and Molkentin, J. D. (2000) Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology. Trends Cardiovasc. Med. 10, 19-22 (Pubitemid 32012677)
105. Heidenreich, O., Neininger, A., Schratt, G., Zinck, R., Cahill, M. A., Engel, K., Kotlyarov, A., Kraft, R., Kostka, S., Gaestel, M. et al. (1999) MAPKAP kinase 2 phosphorylates serum response factor in vitro and in vivo. J. Biol. Chem. 274, 14434-14443
106. Ambrosino, C., Iwata, T., Scafoglio, C., Mallardo, M., Klein, R. and Nebreda, A. R. (2006) TEF-1 and C/EBPβ are major p38α MAPK-regulated transcription factors in proliferating cardiomyocytes. Biochem. J. 396, 163-172 (Pubitemid 43764508)
107. Chang, J., Sonoyama, W., Wang, Z., Jin, Q., Zhang, C., Krebsbach, P. H., Giannobile, W., Shi, S. and Wang, C. Y. (2007) Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK. J. Biol. Chem. 282, 30938-30948 (Pubitemid 350035235)
108. Li, J., Zhao, Z., Yang, J., Liu, J., Wang, J., Li, X. and Liu, Y. (2009) p38 MAPK mediated in compressive stress-induced chondrogenesis of rat bone marrow MSCs in 3D alginate scaffolds. J. Cell. Physiol. 221, 609-617
109. Kawaki, H., Kubota, S., Suzuki, A., Suzuki, M., Kohsaka, K., Hoshi, K., Fujii, T., Lazar, N., Ohgawara, T., Maeda, T. et al. (2011) Differential roles of CCN family proteins during osteoblast differentiation: involvement of Smad and MAPK signaling pathways. Bone 49, 975-989
110. Greenblatt, M. B., Shim, J. H., Zou, W., Sitara, D., Schweitzer, M., Hu, D., Lotinun, S., Sano, Y., Baron, R., Park, J. M. et al. (2010) The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J. Clin. Invest. 120, 2457-2473
111. Nakajima, A., Sanjay, A., Chiusaroli, R., Adapala, N. S., Neff, L., Itzsteink, C., Horne, W. C. and Baron, R. (2009) Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia. J. Bone Miner. Res. 24, 1162-1172
112. Maekawa, T., Jin, W. and Ishii, S. (2010) The role of ATF-2 family transcription factors in adipocyte differentiation: antiobesity effects of p38 inhibitors. Mol. Cell. Biol. 30, 613-625
113. Bhandari, D. R., Seo, K. W., Roh, K. H., Jung, J. W., Kang, S. K. and Kang, K. S. (2010) REX-1 expression and p38 MAPK activation status can determine proliferation/differentiation fates in human mesenchymal stem cells. PLoS ONE 5, e10493
114. Sellayah, D., Bharaj, P. and Sikder, D. (2011) Orexin is required for brown adipose tissue development, differentiation, and function. Cell. Metab. 14, 478-490
115. Hanley, S. and Rosenberg, L. (2007) Transforming growth factor β is a critical regulator of adult human islet plasticity. Mol. Endocrinol. 21, 1467-1477 (Pubitemid 46984751)
116. Hamamoto, K., Yamada, S., Hara, A., Kodera, T., Seno, M. and Kojima, I. (2011) Extracellular matrix modulates insulin production during differentiation of AR42J cells: functional role of Pax6 transcription factor. J. Cell Biochem. 112, 318-329
117. Ogihara, T., Watada, H., Kanno, R., Ikeda, F., Nomiyama, T., Tanaka, Y., Nakao, A., German, M. S., Kojima, I. and Kawamori, R. (2003) p38 MAPK is involved in activin Aand hepatocyte growth factor-mediated expression of pro-endocrine gene neurogenin 3 in AR42J-B13 cells. J. Biol. Chem. 278, 21693-21700 (Pubitemid 36792571)
118. Yuan, L., Yu, Y., Sanders, M. A., Majumdar, A. P. and Basson, M. D. (2010) Schlafen 3 induction by cyclic strain regulates intestinal epithelial differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G994-G1003
119. Kim, M. J., Park, B. J., Kang, Y. S., Kim, H. J., Park, J. H., Kang, J. W., Lee, S. W., Han, J. M., Lee, H. W. and Kim, S. (2003) Downregulation of FUSE-binding protein and c-myc by tRNA synthetase cofactor p38 is required for lung cell differentiation. Nat. Genet. 34, 330-336 (Pubitemid 36792868)
120. Land, S. C. and Darakhshan, F. (2004) Thymulin evokes IL-6-C/EBPβ regenerative repair and TNF-α silencing during endotoxin exposure in fetal lung explants. Am. J. Physiol. Lung Cell. Mol. Physiol. 286, L473-L487 (Pubitemid 38233617)
121. Kolosova, I., Nethery, D. and Kern, J. A. (2011) Role of Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal transition of pulmonary epithelial cells. J. Cell. Physiol. 226, 1248-1254
122. Dong, J., Huang, S., Caikovski, M., Ji, S., McGrath, A., Custorio, M. G., Creighton, C. J., Maliakkal, P., Bogoslovskaia, E., Du, Z. et al. (2011) ID4 regulates mammary gland development by suppressing p38MAPK activity. Development 138, 5247-5256
123. Hsu, S., Dickinson, D., Borke, J., Walsh, D. S., Wood, J., Qin, H., Winger, J., Pearl, H., Schuster, G. and Bollag, W. B. (2007) Green tea polyphenol induces caspase 14 in epidermal keratinocytes via MAPK pathways and reduces psoriasiform lesions in the flaky skin mouse model. Exp. Dermatol. 16, 678-684 (Pubitemid 47079598)
124. Connelly, J. T., Mishra, A., Gautrot, J. E. and Watt, F. M. (2011) Shape-induced terminal differentiation of human epidermal stem cells requires p38 and is regulated by histone acetylation. PLoS ONE 6, e27259
125. Kumar, S., Boehm, J. and Lee, J. C. (2003) p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2, 717-726 (Pubitemid 37361787)
126. Johnson, G. V. and Bailey, C. D. (2003) The p38 MAP kinase signaling pathway in Alzheimer's disease. Exp. Neurol. 183, 263-268 (Pubitemid 37205068)
127. Broom, O. J., Widjaya, B., Troelsen, J., Olsen, J. and Nielsen, O. H. (2009) Mitogen activated protein kinases: a role in inflammatory bowel disease? Clin. Exp. Immunol. 158, 272-280
128. McFarland, L. V. (2008) State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008. World J. Gastroenterol. 14, 2625-2629
129. Baumgart, D. C. and Carding, S. R. (2007) Inflammatory bowel disease: cause and immunobiology. Lancet 369, 1627-1640 (Pubitemid 46722636)
130. Bassi, R., Heads, R., Marber, M. S. and Clark, J. E. (2008) Targeting p38-MAPK in the ischaemic heart: kill or cure? Curr. Opin. Pharmacol. 8, 141-146
131. Chung, K. F. and Adcock, I. M. (2008) Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur. Respir. J. 31, 1334-1356
132. Coulthard, L. R., White, D. E., Jones, D. L., McDermott, M. F. and Burchill, S. A. (2009) p38MAPK: stress responses from molecular mechanisms to therapeutics. Trends Mol. Med. 15, 369-379
133. Cuenda, A. and Rousseau, S. (2007) p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 1773, 1358-1375 (Pubitemid 47125981)
134. Mbalaviele, G., Anderson, G., Jones, A., De Ciechi, P., Settle, S., Mnich, S., Thiede, M., Abu-Amer, Y., Portanova, J. and Monahan, J. (2006) Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction. J. Pharmacol. Exp. Ther. 317, 1044-1053 (Pubitemid 43764107)
135. Ridley, S. H., Sarsfield, S. J., Lee, J. C., Bigg, H. F., Cawston, T. E., Taylor, D. J., DeWitt, D. L. and Saklatvala, J. (1997) Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J. Immunol. 158, 3165-3173 (Pubitemid 127484030)
136. Murphy, L. O. and Blenis, J. (2006) MAPK signal specificity: the right place at the right time. Trends Biochem. Sci. 31, 268-275 (Pubitemid 43674354)
137. Tobiume, K., Matsuzawa, A., Takahashi, T., Nishitoh, H., Morita, K., Takeda, K., Minowa, O., Miyazono, K., Noda, T. and Ichijo, H. (2001) ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2, 222-228 (Pubitemid 32273301)
138. Roulston, A., Reinhard, C., Amiri, P. and Williams, L. T. (1998) Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor α. J. Biol. Chem. 273, 10232-10239 (Pubitemid 28227625)
139. Okuma-Yoshioka, C., Seto, H., Kadono, Y., Hikita, A., Oshima, Y.,
140. Zwerina, J., Hayer, S., Redlich, K., Bobacz, K., Kollias, G., Smolen, J. S. and Schett, G. (2006) Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction. Arthritis Rheum. 54, 463-472 (Pubitemid 43228620)
141. Ip, W. K., Wong, C. K. and Lam, C. W. (2006) Interleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1/2 signalling pathways. Clin. Exp. Immunol. 145, 162-172 (Pubitemid 43893946)
142. Reiner, S. L. (2007) Development in motion: helper T cells at work. Cell 129, 33-36
143. Danese, S., Semeraro, S., Marini, M., Roberto, I., Armuzzi, A., Papa, A. and Gasbarrini, A. (2005) Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation. Dig. Liver Dis. 37, 811-818 (Pubitemid 44356115)
144. Fiocchi, C. (1997) Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions. Am. J. Physiol. 273, G769-G775
145. Scaldaferri, F., Sans, M., Vetrano, S., Correale, C., Arena, V., Pagano, N., Rando, G., Romeo, F., Potenza, A. E., Repici, A. et al. (2009) The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease. Eur. J. Immunol. 39, 290-300
146. Ferrer, I., Blanco, R., Carmona, M., Puig, B., Barrachina, M., Gomez, C. and Ambrosio, S. (2001) Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and dementia with Lewy bodies. J. Neural Transm. 108, 1383-1396 (Pubitemid 34020444)
147. Culbert, A. A., Skaper, S. D., Howlett, D. R., Evans, N. A., Facci, L., Soden, P. E., Seymour, Z. M., Guillot, F., Gaestel, M. and Richardson, J. C. (2006) MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease. J. Biol. Chem. 281, 23658-23667 (Pubitemid 44274141)
148. Feijoo, C., Campbell, D. G., Jakes, R., Goedert, M. and Cuenda, A. (2005) Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38δ at Thr50 promotes microtubule assembly. J. Cell Sci. 118, 397-408 (Pubitemid 40277351)
149. Hanger, D. P., Anderton, B. H. and Noble, W. (2009) Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol. Med. 15, 112-119
150. Jin, S. X., Zhuang, Z. Y., Woolf, C. J. and Ji, R. R. (2003) p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 23, 4017-4022 (Pubitemid 36958419)
151. Xu, J. T., Xin, W. J., Wei, X. H., Wu, C. Y., Ge, Y. X., Liu, Y. L., Zang, Y., Zhang, T., Li, Y. Y. and Liu, X. G. (2007) p38 activation in uninjured primary afferent neurons and in spinal microglia contributes to the development of neuropathic pain induced by selective motor fiber injury. Exp. Neurol. 204, 355-365 (Pubitemid 46330283)
152. Mao, Z. and Wiedmann, M. (1999) Calcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neurons. J. Biol. Chem. 274, 31102-31107
153. Muslin, A. J. (2008) MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin. Sci. 115, 203-218
154. Engel, F. B. (2005) Cardiomyocyte proliferation: a platform for mammalian cardiac repair. Cell Cycle 4, 1360-1363
155. Kaiser, R. A., Bueno, O. F., Lips, D. J., Doevendans, P. A., Jones, F., Kimball, T. F. and Molkentin, J. D. (2004) Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo. J. Biol. Chem. 279, 15524-15530 (Pubitemid 38618953)
156. Frantz, S., Behr, T., Hu, K., Fraccarollo, D., Strotmann, J., Goldberg, E., Ertl, G., Angermann, C. E. and Bauersachs, J. (2007) Role of p38 mitogen-activated protein kinase in cardiac remodelling. Br. J. Pharmacol. 150, 130-135 (Pubitemid 46160602)
157. Streicher, J. M., Ren, S., Herschman, H. and Wang, Y. (2010) MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. Circ. Res. 106, 1434-1443
158. Zhou, L., Opalinska, J. and Verma, A. (2007) p38 MAP kinase regulates stem cell apoptosis in human hematopoietic failure. Cell Cycle 6, 534-537 (Pubitemid 46440424)
159. Chang, Y. I., Hua, W. K., Yao, C. L., Hwang, S. M., Hung, Y. C., Kuan, C. J., Leou, J. S. and Lin, W. J. (2010) Protein-arginine methyltransferase 1 suppresses megakaryocytic differentiation via modulation of the p38 MAPK pathway in K562 cells. J. Biol. Chem. 285, 20595-20606
160. da Costa, S. V., Roela, R. A., Junqueira, M. S., Arantes, C. and Brentani, M. M. (2010) The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes. Leuk. Res. 34, 507-512
161. Fatrai, S., van Gosliga, D., Han, L., Daenen, S. M., Vellenga, E. and Schuringa, J. J. (2011) KRAS(G12V) enhances proliferation and initiates myelomonocytic differentiation in human stem/progenitor cells via intrinsic and extrinsic pathways. J. Biol. Chem. 286, 6061-6070
162. Mayer, I. A., Verma, A., Grumbach, I. M., Uddin, S., Lekmine, F., Ravandi, F., Majchrzak, B., Fujita, S., Fish, E. N. and Platanias, L. C. (2001) The p38 MAPK pathway mediates the growth inhibitory effects of interferon-α in BCR-ABL-expressing cells. J. Biol. Chem. 276, 28570-28577
163. Bulavin, D. V. and Fornace, Jr, A. J. (2004) p38 MAP kinase's emerging role as a tumor suppressor. Adv. Cancer Res. 92, 95-118 (Pubitemid 39458114)
164. Han, J. and Sun, P. (2007) The pathways to tumor suppression via route p38. Trends Biochem. Sci. 32, 364-371 (Pubitemid 47126858)
165. Haq, R., Brenton, J. D., Takahashi, M., Finan, D., Finkielsztein, A., Damaraju, S., Rottapel, R. and Zanke, B. (2002) Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Res. 62, 5076-5082 (Pubitemid 34987550)
166. Wang, W., Chen, J. X., Liao, R., Deng, Q., Zhou, J. J., Huang, S. and Sun, P. (2002) Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic Ras-induced premature senescence. Mol. Cell. Biol. 22, 3389-3403 (Pubitemid 34453979)
167. Puri, P. L., Wu, Z., Zhang, P., Wood, L. D., Bhakta, K. S., Han, J., Feramisco, J. R., Karin, M. and Wang, J. Y. (2000) Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev. 14, 574-584 (Pubitemid 30159776)
168. Rossi, S., Stoppani, E., Puri, P. L. and Fanzani, A. (2011) Differentiation of human rhabdomyosarcoma RD cells is regulated by reciprocal, functional interactions between myostatin, p38 and extracellular regulated kinase signalling pathways. Eur. J. Cancer 47, 1095-1105
169. Noel, J. K., Crean, S., Claflin, J. E., Ranganathan, G., Linz, H. and Lahn, M. (2008) Systematic review to establish the safety profiles for direct and indirect inhibitors of p38 mitogen-activated protein kinases for treatment of cancer. A systematic review of the literature. Med. Oncol. 25, 323-330